Elysium Therapeutics, Inc.
Biotechnology company · Akron, Ohio, United States
Elysium Therapeutics, Inc. is a biotechnology company headquartered in Akron, Ohio, United States. Its earliest recorded incorporation is in 2013. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $6.7 million in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $2.2 million sold in a notice filed in 2022.
Elysium Therapeutics at a glance
What does Elysium Therapeutics do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $6.7 million in total (2014 to 2018). NIH funding came from the National Institute on Drug Abuse.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $2.2 million sold (2022).
Frequently asked questions about Elysium Therapeutics
Where is Elysium Therapeutics headquartered?
Elysium Therapeutics, Inc. is headquartered in Akron, Ohio, United States.
What does Elysium Therapeutics do?
Elysium Therapeutics, Inc. is a biotechnology company.
When was Elysium Therapeutics founded?
The earliest incorporation on record for Elysium Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.